Cutaneous Recall Phenomenon with Vinorelbine

Valencak J , Troch M , Raderer M . Cutaneous recall phenomenon at the site of previous doxorubicin extravasation after second-line chemotherapy. J Nad Cancer Inst 2007; 99:177–8. DOI 10.1093/jnci/djk027

Wilson J , Carder P , Gooi J . Recall phenomenon following epirubicin. Clin Oncol (R Coll of Radiol) 1999; 11:424–5.

Bairey O , Bishara J , Stahl B . Severe tissue necrosis after cisplatin extravasation at low concentration: possible “immediate recall phenomenon.” J Nad Cancer Inst 1997; 89:1233–4.

Ley BD , Millan GG , Perez JS . Docetaxel recall phenomenon at the site of previous drug extravasation. Arch Dermatol 2010; 146:1190–1. DOI 10.1001/archdermatol.2010291

Cicchetti S , Jemec B , Gault DT . Two case reports of vinorelbine extravasation: management and review of the literature. Tumori 2000; 86:289–92.

Dorr RT , Bool KL . Antidote studies of vinorelbine-induced skin ulceration in the mouse. Cancer Chemother Pharmacol 1995; 36:290–2.

Solimando DA . Drug information handbook for oncology: a complete guide to combination chemotherapy regimens. 8th ed. Hudson, Ohio: Lexi-Comp, Inc., 2010.

Naranjo CA , Busto M , Sellers EM . A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239–45.